2026 Q1 -tulosraportti
40 päivää sitten
‧1 t 2 min
7,95 DKK/osake
Viimeisin osinko
4,07%Tuotto/v
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 152 | - | - | ||
| 295 | - | - | ||
| 37 | - | - | ||
| 81 | - | - | ||
| 48 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 841 611 | 1 841 611 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 841 611 | 1 841 611 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 5.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
·17 min sittenThe Novo Nordisk stock suddenly rises by 2 pct., and this could be due to interest from the USA, estimates chief trader Mads Zink from Danske Bank. Well done, chief trader Mads. Extremely significant development… 🙄
·58 min sitten · MuokattuIf Trump Jr asked if he could get both Greenland and Zealand included in the purchase with a promise of a price of 600, then many of us would immediately sell the social experiments and save a little on taxes.
1 t sitten1 t sitten"Novo Nordisk expects to repurchase B shares for an amount up to DKK 15 billion during a 12-month period beginning 4 February 2026. As of 12 June 2026, Novo Nordisk has since 4 February 2026 repurchased a total 19,884,179 B shares at an average share price of DKK 264.99 per B share equal to a transaction value of DKK 5,269,055,819."
·1 t sittenTechnical analysis by Gemini: Long-term (200-day moving average): The stock remains below its 200-day moving average (MA200 is around price 286.8 - 303.6 depending on the precise timeframe). This signals that the overall, long-term primary trend still has a negative bias after the major correction. Medium-term (50-day moving average): Here we see a clear reversal. The price is currently around 287 DKK, which is almost 7% above the 50-day moving average (MA50 is around 268-276 DKK). This indicates that the medium-term trend is about to turn positive. Short-term (20-day moving average): The stock is in a short-term uptrend and is currently consolidating stably above MA20 (around 284-285 DKK). Support and resistance levels After the deep fall, the stock has established some very clear technical levels that govern the current price development: Most Important Support (Support): The bottom levels around price 228 held firm as a solid bottom. Subsequently, the resistance at price 246 has been broken and now functions as the primary strong support line in case of new declines. In the very short term, the area around price 280 also provides minor support. Most Important Resistance (Resistance): The stock is currently testing a very crucial resistance level around price 285 - 287. If the stock can close and establish itself above price 287 (a so-called established breakout), a strong technical buy signal is triggered. The next major resistance level is then all the way up around price 311 - 312 (which also matches the average fundamental price target from analysts) and then price 390. Technical Indicators (Momentum) RSI (Relative Strength Index): Is at 55 - 66 (depending on daily/weekly timeframe). It has climbed out of the "oversold" zone, but is not yet "overbought" (which is >70). This means that there is still technical room for further price increases before momentum becomes too stretched. MACD: Shows a mixed, but improved picture. On the short weekly and daily charts, MACD has turned around and is pointing upwards, which shows that the massive selling pressure (headwind) is finally subsiding, and buyers are taking control. Overall Conclusion & Strategy The technical signal for Novo Nordisk can currently be described as "Wait with a positive undertone". The stock has overcome its worst decline and has formed a solid bottom structure. Right now, it is in a "make-or-break" resistance area. For the cautious investor: Await a clear and established breakout above price 287 on solid volume. If that happens, a significant rally opens up (up to 40% technical potential towards the next major resistance zones). For the aggressive investor: One can accumulate close to the moving averages (around price 280-284) with a relatively tight stop-loss placed just below the support levels of recent weeks.
·4 min sittenI think it's much more positive that the price has just climbed above the 100-day moving GNS, after which the next target is the 200-day moving GNS. So show patience and we will be rewarded:-)
·1 t sittenRelations with Washington are probably better than no relations. If the Trump family or people close to the administration visit Novo, it is usually a sign of dialogue rather than conflict. It is not necessarily bullish, but it is also not a red flag in itself.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
40 päivää sitten
‧1 t 2 min
7,95 DKK/osake
Viimeisin osinko
4,07%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·17 min sittenThe Novo Nordisk stock suddenly rises by 2 pct., and this could be due to interest from the USA, estimates chief trader Mads Zink from Danske Bank. Well done, chief trader Mads. Extremely significant development… 🙄
- ·58 min sitten · MuokattuIf Trump Jr asked if he could get both Greenland and Zealand included in the purchase with a promise of a price of 600, then many of us would immediately sell the social experiments and save a little on taxes.
- 1 t sitten1 t sitten"Novo Nordisk expects to repurchase B shares for an amount up to DKK 15 billion during a 12-month period beginning 4 February 2026. As of 12 June 2026, Novo Nordisk has since 4 February 2026 repurchased a total 19,884,179 B shares at an average share price of DKK 264.99 per B share equal to a transaction value of DKK 5,269,055,819."
- ·1 t sittenTechnical analysis by Gemini: Long-term (200-day moving average): The stock remains below its 200-day moving average (MA200 is around price 286.8 - 303.6 depending on the precise timeframe). This signals that the overall, long-term primary trend still has a negative bias after the major correction. Medium-term (50-day moving average): Here we see a clear reversal. The price is currently around 287 DKK, which is almost 7% above the 50-day moving average (MA50 is around 268-276 DKK). This indicates that the medium-term trend is about to turn positive. Short-term (20-day moving average): The stock is in a short-term uptrend and is currently consolidating stably above MA20 (around 284-285 DKK). Support and resistance levels After the deep fall, the stock has established some very clear technical levels that govern the current price development: Most Important Support (Support): The bottom levels around price 228 held firm as a solid bottom. Subsequently, the resistance at price 246 has been broken and now functions as the primary strong support line in case of new declines. In the very short term, the area around price 280 also provides minor support. Most Important Resistance (Resistance): The stock is currently testing a very crucial resistance level around price 285 - 287. If the stock can close and establish itself above price 287 (a so-called established breakout), a strong technical buy signal is triggered. The next major resistance level is then all the way up around price 311 - 312 (which also matches the average fundamental price target from analysts) and then price 390. Technical Indicators (Momentum) RSI (Relative Strength Index): Is at 55 - 66 (depending on daily/weekly timeframe). It has climbed out of the "oversold" zone, but is not yet "overbought" (which is >70). This means that there is still technical room for further price increases before momentum becomes too stretched. MACD: Shows a mixed, but improved picture. On the short weekly and daily charts, MACD has turned around and is pointing upwards, which shows that the massive selling pressure (headwind) is finally subsiding, and buyers are taking control. Overall Conclusion & Strategy The technical signal for Novo Nordisk can currently be described as "Wait with a positive undertone". The stock has overcome its worst decline and has formed a solid bottom structure. Right now, it is in a "make-or-break" resistance area. For the cautious investor: Await a clear and established breakout above price 287 on solid volume. If that happens, a significant rally opens up (up to 40% technical potential towards the next major resistance zones). For the aggressive investor: One can accumulate close to the moving averages (around price 280-284) with a relatively tight stop-loss placed just below the support levels of recent weeks.·4 min sittenI think it's much more positive that the price has just climbed above the 100-day moving GNS, after which the next target is the 200-day moving GNS. So show patience and we will be rewarded:-)
- ·1 t sittenRelations with Washington are probably better than no relations. If the Trump family or people close to the administration visit Novo, it is usually a sign of dialogue rather than conflict. It is not necessarily bullish, but it is also not a red flag in itself.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 152 | - | - | ||
| 295 | - | - | ||
| 37 | - | - | ||
| 81 | - | - | ||
| 48 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 841 611 | 1 841 611 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 841 611 | 1 841 611 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 5.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 |
2026 Q1 -tulosraportti
40 päivää sitten
‧1 t 2 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 5.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 |
7,95 DKK/osake
Viimeisin osinko
4,07%Tuotto/v
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·17 min sittenThe Novo Nordisk stock suddenly rises by 2 pct., and this could be due to interest from the USA, estimates chief trader Mads Zink from Danske Bank. Well done, chief trader Mads. Extremely significant development… 🙄
- ·58 min sitten · MuokattuIf Trump Jr asked if he could get both Greenland and Zealand included in the purchase with a promise of a price of 600, then many of us would immediately sell the social experiments and save a little on taxes.
- 1 t sitten1 t sitten"Novo Nordisk expects to repurchase B shares for an amount up to DKK 15 billion during a 12-month period beginning 4 February 2026. As of 12 June 2026, Novo Nordisk has since 4 February 2026 repurchased a total 19,884,179 B shares at an average share price of DKK 264.99 per B share equal to a transaction value of DKK 5,269,055,819."
- ·1 t sittenTechnical analysis by Gemini: Long-term (200-day moving average): The stock remains below its 200-day moving average (MA200 is around price 286.8 - 303.6 depending on the precise timeframe). This signals that the overall, long-term primary trend still has a negative bias after the major correction. Medium-term (50-day moving average): Here we see a clear reversal. The price is currently around 287 DKK, which is almost 7% above the 50-day moving average (MA50 is around 268-276 DKK). This indicates that the medium-term trend is about to turn positive. Short-term (20-day moving average): The stock is in a short-term uptrend and is currently consolidating stably above MA20 (around 284-285 DKK). Support and resistance levels After the deep fall, the stock has established some very clear technical levels that govern the current price development: Most Important Support (Support): The bottom levels around price 228 held firm as a solid bottom. Subsequently, the resistance at price 246 has been broken and now functions as the primary strong support line in case of new declines. In the very short term, the area around price 280 also provides minor support. Most Important Resistance (Resistance): The stock is currently testing a very crucial resistance level around price 285 - 287. If the stock can close and establish itself above price 287 (a so-called established breakout), a strong technical buy signal is triggered. The next major resistance level is then all the way up around price 311 - 312 (which also matches the average fundamental price target from analysts) and then price 390. Technical Indicators (Momentum) RSI (Relative Strength Index): Is at 55 - 66 (depending on daily/weekly timeframe). It has climbed out of the "oversold" zone, but is not yet "overbought" (which is >70). This means that there is still technical room for further price increases before momentum becomes too stretched. MACD: Shows a mixed, but improved picture. On the short weekly and daily charts, MACD has turned around and is pointing upwards, which shows that the massive selling pressure (headwind) is finally subsiding, and buyers are taking control. Overall Conclusion & Strategy The technical signal for Novo Nordisk can currently be described as "Wait with a positive undertone". The stock has overcome its worst decline and has formed a solid bottom structure. Right now, it is in a "make-or-break" resistance area. For the cautious investor: Await a clear and established breakout above price 287 on solid volume. If that happens, a significant rally opens up (up to 40% technical potential towards the next major resistance zones). For the aggressive investor: One can accumulate close to the moving averages (around price 280-284) with a relatively tight stop-loss placed just below the support levels of recent weeks.·4 min sittenI think it's much more positive that the price has just climbed above the 100-day moving GNS, after which the next target is the 200-day moving GNS. So show patience and we will be rewarded:-)
- ·1 t sittenRelations with Washington are probably better than no relations. If the Trump family or people close to the administration visit Novo, it is usually a sign of dialogue rather than conflict. It is not necessarily bullish, but it is also not a red flag in itself.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 152 | - | - | ||
| 295 | - | - | ||
| 37 | - | - | ||
| 81 | - | - | ||
| 48 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 841 611 | 1 841 611 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 841 611 | 1 841 611 | 0 | 0 |